Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04906824

Post-Market Registry in Europe and US for the Use of VascuCelTM

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
LeMaitre Vascular · Industry
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This is a post-market, multi-centre, open-label registry designed to collect prospective safety and performance data on the use of VascuCel in patients who require great vessel reconstruction, peripheral vascular reconstruction or suture line buttressing. This registry will collect safety and performance data up to 2 years following implantation.

Detailed description

Post-market, prospective, multi-centre, open-label, registry designed to collect prospective safety and performance data on the use of VascuCel in patients with vascular disorders and in accordance with local standard of care. The Registry has been designed to collect data up to 2 years following implantation. The VascuCel Registry will collect data on the use of the VascuCel, for the following major indications: * Great vessel reconstruction * Peripheral vascular reconstruction As suture line buttressing is a procedure that does not consistently use tissue, data on this indication will only be included if available. Data will be prospectively collected by the sites on registry-specific electronic case report forms (eCRFs). The primary endpoints will assess device's safety and performance through measures and images obtained via the facility's standard of care at the respective registry site. Additional data will also be collected from the implant procedure to assess user (surgeon) satisfaction with the devices' handling and performance.

Conditions

Interventions

TypeNameDescription
DEVICEgreat vessel reconstruction; peripheral vascular reconstruction; suture line buttressingVascuCel implantation in order to perform great vessel reconstruction; peripheral vascular reconstruction; suture line buttressing

Timeline

Start date
2023-06-09
Primary completion
2025-10-01
Completion
2026-09-01
First posted
2021-05-28
Last updated
2025-03-10

Locations

5 sites across 2 countries: United States, Italy

Source: ClinicalTrials.gov record NCT04906824. Inclusion in this directory is not an endorsement.